{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:46:48Z","timestamp":1776098808568,"version":"3.50.1"},"publisher-location":"Cham","reference-count":44,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030504939","type":"print"},{"value":"9783030504946","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/164_2020_359","type":"book-chapter","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T09:02:38Z","timestamp":1590483758000},"page":"193-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Arterial Hypertension in Children"],"prefix":"10.1007","author":[{"given":"Wolfgang","family":"Rascher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Paech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"key":"359_CR1","first-page":"55","volume":"39","author":"H Bachmann","year":"1984","unstructured":"Bachmann H (1984) Propranolol versus chlorthalidone \u2013 a prospective therapeutic trial in children with chronic hypertension. Helv Paediatr Acta 39:55\u201361","journal-title":"Helv Paediatr Acta"},{"key":"359_CR2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpeds.2006.09.034","volume":"150","author":"DL Batisky","year":"2007","unstructured":"Batisky DL, Sorof JM, Sugg J et al (2007) Efficacy and safety of extended release metoprolol succinate in hypertensive children 6 to 16 years of age: a clinical trial experience. J Pediatr 150:134\u2013139","journal-title":"J Pediatr"},{"key":"359_CR3","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/HYPERTENSIONAHA.107.108886","volume":"51","author":"DK Benjamin Jr","year":"2008","unstructured":"Benjamin DK Jr, Smith PB, Jadhav P et al (2008) Pediatric antihypertensive trial failures: analysis of end points and dose range. Hypertension 51:834\u2013840","journal-title":"Hypertension"},{"key":"359_CR4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.103.6.904","volume":"103","author":"M Burnier","year":"2001","unstructured":"Burnier M (2001) Angiotensin II type 1 receptor blockers. Circulation 103:904\u2013912","journal-title":"Circulation"},{"key":"359_CR5","first-page":"CD008117","volume":"2","author":"S Chaturvedi","year":"2014","unstructured":"Chaturvedi S, Lipszyc DH, Licht C et al (2014) Pharmacological interventions for hypertension in children. Cochrane Database Syst Rev 2:CD008117","journal-title":"Cochrane Database Syst Rev"},{"key":"359_CR6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4330\/wjc.v6.i5.234","volume":"6","author":"PY Chu","year":"2014","unstructured":"Chu PY, Campbell MJ, Miller SG, Hill KD (2014) Anti-hypertensive drugs in children and adolescents. World J Cardiol 6:234\u2013244","journal-title":"World J Cardiol"},{"key":"359_CR7","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa055202","volume":"354","author":"WO Cooper","year":"2006","unstructured":"Cooper WO, Hernandez-Diaz S, Arbogast PG et al (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354:2443\u20132451","journal-title":"N Engl J Med"},{"key":"359_CR8","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","volume":"361","author":"E W\u00fchl","year":"2009","unstructured":"ESCAPE Trial Group, W\u00fchl E, Trivelli A, Picca S et al (2009) Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361:1639\u20131650","journal-title":"N Engl J Med"},{"key":"359_CR9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jpeds.2004.04.009","volume":"145","author":"JT Flynn","year":"2004","unstructured":"Flynn JT, Newburger JW, Daniels SR et al (2004) A randomized, placebo-controlled trial of amlodipine in children with hypertension. J Pediatr 145:353\u2013359","journal-title":"J Pediatr"},{"key":"359_CR10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/HYPERTENSIONAHA.108.111054","volume":"52","author":"JT Flynn","year":"2008","unstructured":"Flynn JT, Meyers KE, Neto JP, Pediatric Valsartan Study Group et al (2008) Efficacy and safety of the angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 years. Hypertension 52:222\u2013228","journal-title":"Hypertension"},{"key":"359_CR11","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/HYPERTENSIONAHA.109.147702","volume":"55","author":"L Hazan","year":"2010","unstructured":"Hazan L, Hern\u00e1ndez Rodriguez OA, Bhorat AE et al (2010) A double-blind, dose-response study of the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension. Hypertension 55:1323\u20131330","journal-title":"Hypertension"},{"key":"359_CR12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00467-006-0399-5","volume":"22","author":"RJ Hogg","year":"2007","unstructured":"Hogg RJ, Delucchi A, Sakihara G et al (2007) A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension. Pediatr Nephrol 22:695\u2013701","journal-title":"Pediatr Nephrol"},{"key":"359_CR13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0030-1269895","volume":"223","author":"C H\u00fcnseler","year":"2011","unstructured":"H\u00fcnseler C, Paneitz A, Friedrich D et al (2011) Angiotensin II receptor blocker induced fetopathy: 7 cases. Klin Padiatr 223:5\u20139","journal-title":"Klin Padiatr"},{"key":"359_CR14","unstructured":"International Pediatric Nephrology Association (IPNA) (2011) (updated January 2012) ( http:\/\/www.iphapediatrichypertension.org\/wp-core\/wp-content\/uploads\/BPLimitsChart0112.pdf ). Accessed 8 Feb 2020"},{"key":"359_CR15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/01.HYP.0000138069.68413.f0","volume":"44","author":"JS Li","year":"2004","unstructured":"Li JS, Berezny K, Kilaru R et al (2004) Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children? Hypertension 44:289\u2013293","journal-title":"Hypertension"},{"issue":"10","key":"359_CR16","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","volume":"34","author":"E Lurbe","year":"2016","unstructured":"Lurbe E, Agabiti-Rosei E, Cruickshank JK et al (2016) 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 34(10):1887\u20131920","journal-title":"J Hypertens"},{"key":"359_CR17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ahj.2005.12.025","volume":"152","author":"S Menon","year":"2006","unstructured":"Menon S, Berezny KY, Kilaru R et al (2006) Racial differences are seen in blood pressure response to fosinopril in hypertensive children. Am Heart J 152:394\u2013399","journal-title":"Am Heart J"},{"key":"359_CR18","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.clinthera.2011.09.003","volume":"33","author":"RS Meyers","year":"2011","unstructured":"Meyers RS, Siu A (2011) Pharmacotherapy review of chronic pediatric hypertension. Clin Ther 33:1331\u20131356","journal-title":"Clin Ther"},{"key":"359_CR19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1542\/peds.75.6.1091","volume":"75","author":"BL Mirkin","year":"1985","unstructured":"Mirkin BL, Newman TJ (1985) Efficacy and safety of captopril in the treatment of severe childhood hypertension: report of the International Collaborative Study Group. Pediatrics 75:1091\u20131100","journal-title":"Pediatrics"},{"key":"359_CR20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1203\/00006450-197704000-00295","volume":"11","author":"BL Mirkin","year":"1977","unstructured":"Mirkin BL, Sinaiko AR, Cooper M, Anders M (1977) Hydrochlorothiazide therapy in hypertensive and renal insufficient children: elimination kinetics and metabolic effects. Pediatr Res 11:418","journal-title":"Pediatr Res"},{"key":"359_CR21","doi-asserted-by":"crossref","first-page":"e978","DOI":"10.1542\/peds.2010-1290","volume":"127","author":"HK Neuhauser","year":"2011","unstructured":"Neuhauser HK, Thamm M, Ellert U et al (2011) Blood pressure percentiles by age and height from nonoverweight children and adolescents in Germany. Pediatrics 127:e978\u2013e988","journal-title":"Pediatrics"},{"key":"359_CR22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jaad.2017.11.042","volume":"78","author":"SA Pedersen","year":"2018","unstructured":"Pedersen SA, Gaist D, Schmidt SAJ et al (2018) Hydrochlorothiazide use and risk of nonmelanoma skin cancer: a nationwide casecontral study fram Denmark. J Am Acad Dermatol 78:673\u2013681","journal-title":"J Am Acad Dermatol"},{"key":"359_CR23","unstructured":"Pharmacovigilance Risk Assessment Committee (PRAC) (2018) PRAC recommendations on signals. EMA\/PRAC\/595691\/2018 https:\/\/www.ema.europa.eu\/documents\/prac-recommendation\/prac-recommendations-signals-adopted-3-6-september-2018-prac-meeting_en-0.pdf . Accessed 10 Feb 2020"},{"key":"359_CR24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/joim.12629","volume":"282","author":"A Pottegard","year":"2017","unstructured":"Pottegard A, Hallas J, Diesen M et al (2017) Hydrochlorothiazide use is strongly associated with risk of lip cancer. J Intern Med 282:322\u2013331","journal-title":"J Intern Med"},{"key":"359_CR25","first-page":"1825","volume-title":"Textbook of clinical nephrology","author":"W Rascher","year":"2016","unstructured":"Rascher W (2016) Treatment of hypertension in children. In: Turner N, Lameire N, Goldsmith DJ et al (eds) Textbook of clinical nephrology, 4th edn. Oxford University Press, Oxford, pp 1825\u20131830","edition":"4"},{"key":"359_CR26","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/HJH.0b013e328336b86b","volume":"28","author":"F Schaefer","year":"2010","unstructured":"Schaefer F, Van de Walle J, Zurowska A, Candesartan in Children with Hypertension Investigators et al (2010) Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age. J Hypertens 28:1083\u20131090","journal-title":"J Hypertens"},{"key":"359_CR27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00445791","volume":"143","author":"JG Sch\u00f6ber","year":"1984","unstructured":"Sch\u00f6ber JG, Pilossoff W, B\u00fchlmeyer K (1984) Urapidil therapy for acute hypertensive crises in infants and children. Eur J Pediatr 143:87\u201391","journal-title":"Eur J Pediatr"},{"key":"359_CR28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.amjhyper.2004.01.008","volume":"17","author":"T Seeman","year":"2004","unstructured":"Seeman T, Dusek J, Vondr\u00e1k K et al (2004) Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases. Am J Hypertens 17:415\u2013420","journal-title":"Am J Hypertens"},{"issue":"12","key":"359_CR29","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s00467-018-4092-2","volume":"34","author":"T Seeman","year":"2019","unstructured":"Seeman T, Hamdani G, Mitsnefes M (2019) Hypertensive crisis in children and adolescents. Pediatr Nephrol 34(12):2523\u20132537","journal-title":"Pediatr Nephrol"},{"key":"359_CR30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjhyper.2004.09.009","volume":"18","author":"S Shahinfar","year":"2005","unstructured":"Shahinfar S, Cano F, Soffer BA et al (2005) A double-blind, dose-response study of losartan in hypertensive children. Am J Hypertens 18:183\u2013190","journal-title":"Am J Hypertens"},{"key":"359_CR31","doi-asserted-by":"publisher","unstructured":"Siddiqi N, Shatat IF (2019) Antihypertensive agents: a long way to safe drug prescribing in children. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-019-04314-7","DOI":"10.1007\/s00467-019-04314-7"},{"key":"359_CR32","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1097\/HJH.0b013e3282efeb7e","volume":"25","author":"GD Simonetti","year":"2007","unstructured":"Simonetti GD, Rizzi M, Donadini R, Bianchetti MG (2007) Effects of antihypertensive drugs on blood pressure and proteinuria in childhood. J Hypertens 25:2370\u20132376","journal-title":"J Hypertens"},{"key":"359_CR33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/archdischild-2016-310582","volume":"102","author":"E Snauwaert","year":"2017","unstructured":"Snauwaert E, Vande Walle J, De Bruyne P (2017) Therapeutic efficacy and safety of ACE inhibitors in the hypertensive paediatric population: a review. Arch Dis Child 102:63\u201371","journal-title":"Arch Dis Child"},{"key":"359_CR34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s004670000422","volume":"15","author":"M Soergel","year":"2000","unstructured":"Soergel M, Verho M, W\u00fchl E et al (2000) Effect of ramipril on ambulatory blood pressure and albuminuria in renal hypertension. Pediatr Nephrol 15:113\u2013118","journal-title":"Pediatr Nephrol"},{"key":"359_CR35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0895-7061(03)00900-2","volume":"16","author":"B Soffer","year":"2003","unstructured":"Soffer B, Zhang Z, Miller K et al (2003) A double blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension. Am J Hypertens 16:795\u2013800","journal-title":"Am J Hypertens"},{"key":"359_CR36","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1751-7176.2008.00022.x","volume":"10","author":"H Trachtman","year":"2008","unstructured":"Trachtman H, Hainer JW, Sugg J et al (2008) Efficacy, safety, and pharmacokinetics of candesartan cilexetil in children aged 6 to 17 years. J Clin Hypertens 10:743\u2013750","journal-title":"J Clin Hypertens"},{"key":"359_CR37","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1681\/ASN.2018010036","volume":"29","author":"SM Van den Belt","year":"2018","unstructured":"Van den Belt SM, Heerspink HJ, Gracchi V, ESCAPE Trial Group et al (2018) Early proteinuria lowering by angiotensin-converting enzyme inhibition predicts renal survival in children with CKD. J Am Soc Nephrol 29:2225\u20132233","journal-title":"J Am Soc Nephrol"},{"key":"359_CR38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2215\/CJN.06620909","volume":"5","author":"NJ Webb","year":"2010","unstructured":"Webb NJ, Lam C, Loeys T et al (2010) Randomized, double-blind, controlled study of losartan in children with proteinuria. Clin J Am Soc Nephrol 5:417\u2013424","journal-title":"Clin J Am Soc Nephrol"},{"key":"359_CR39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1751-7176.2012.00656.x","volume":"14","author":"WP Welch","year":"2012","unstructured":"Welch WP, Yang W, Taylor-Zapata P, Flynn JT (2012) Antihypertensive drug use by children: are the drugs labeled and indicated? J Clin Hypertens 14:388\u2013395","journal-title":"J Clin Hypertens"},{"key":"359_CR40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1751-7176.2011.00432.x","volume":"13","author":"T Wells","year":"2011","unstructured":"Wells T, Blumer J, Meyers KE et al (2011) Effectiveness and safety of valsartan in children aged 6 to 16 years with hypertension. J Clin Hypertens 13:357\u2013365","journal-title":"J Clin Hypertens"},{"key":"359_CR41","first-page":"401","volume":"14","author":"TG Wells","year":"2012","unstructured":"Wells TG, Blowey DL, Sullivan JE et al (2012) Pharmacokinetics of olmesartan medoxomil in pediatric patients with hypertension. Paediatr Drugs 14:401\u2013409","journal-title":"Paediatr Drugs"},{"key":"359_CR42","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1523-1755.2004.00802.x","volume":"66","author":"E W\u00fchl","year":"2004","unstructured":"W\u00fchl E, Mehls O, Schaefer F, ESCAPE Trial Group (2004) Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 66:768\u2013776","journal-title":"Kidney Int"},{"key":"359_CR43","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s00467-004-1444-x","volume":"19","author":"V Yiu","year":"2004","unstructured":"Yiu V, Orrbine E, Rosychuk RJ et al (2004) The safety and use of short-acting nifedipine in hospitalized hypertensive children. Pediatr Nephrol 19:644\u2013650","journal-title":"Pediatr Nephrol"},{"key":"359_CR44","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2011-0877","volume":"129","author":"EY Yoon","year":"2012","unstructured":"Yoon EY, Cohn L, Rocchini A et al (2012) Antihypertensive prescribing patterns for adolescents with primary hypertension. Pediatrics 129:e1\u2013e8","journal-title":"Pediatrics"}],"container-title":["Handbook of Experimental Pharmacology","Pediatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2020_359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T22:37:28Z","timestamp":1666651048000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2020_359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030504939","9783030504946"],"references-count":44,"URL":"https:\/\/doi.org\/10.1007\/164_2020_359","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"27 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}